1. |
Wang C, Horby PW, Hayden FG, et al. A novel coronavirus outbreak of global health concern. Lancet, 2020, 395(10223): 470-473.
|
2. |
WHO. COVID-19 situation reports. 2021. URL: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed on 2021-05-07.
|
3. |
Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet, 2021, 397(10270): 220-232.
|
4. |
国家卫生健康委疾病预防控制局. 新冠病毒疫苗接种技术指南(第一版). 中国卫生经济, 2021, 40(4): 21.
|
5. |
国家卫生健康委办公厅. 新型冠状病毒肺炎诊疗方案(试行第七版). 传染病信息, 2020, 33(1): 1-6, 26.
|
6. |
宁铁林, 朱效科, 郑敏娜. 天津地区健康人外周血CD4、CD8淋巴细胞正常参考值研究. 中国慢性病预防与控制, 2007, 15(5): 432-434.
|
7. |
蒋卫民, 潘孝彰, 康来仪, 等. 上海地区成人不同年龄组间CD4、CD8淋巴细胞计数正常值调查. 中华传染病杂志, 2002, 20(4): 203-205.
|
8. |
Long QX, Liu BZ, Deng HJ, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med, 2020, 26(6): 845-848.
|
9. |
王星, 吴茜, 李红蔚, 等. 天津地区新型冠状病毒肺炎患者特异性IgM和IgG动态变化研究. 天津医药, 2021, 49(1): 41-44.
|
10. |
Liu C, Yu X, Gao C, et al. Characterization of antibody responses to SARS-CoV-2 in convalescent COVID-19 patients. J Med Virol, 2021, 93(4): 2227-2233.
|
11. |
余珊, 叶祖峰, 陈丽, 等. 41例新型冠状病毒肺炎患者血清抗体检测分析. 微生物学免疫学进展, 2021, 49(1): 48-52.
|
12. |
He Z, Ren L, Yang J, et al. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: A longitudinal, population-level, cross-sectional study. Lancet, 2021, 397(10279): 1075-1084.
|
13. |
Xia S, Duan K, Zhang Y, et al. Effect of an inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes: Interim analysis of 2 randomized clinical trials. JAMA, 2020, 324(10): 951-960.
|
14. |
环球时报. 国药发布疫苗三期数据: 保护效力为79.34%. URL: https://world.huanqiu.com/article/41JrcburUyV. Accessed on 2020-12-31.
|
15. |
国家卫生健康委员会. 国务院联防联控机制2021年3月28日新闻发布会文字实录. URL: http://www.nhc.gov.cn/xcs/fkdt/202103/b8e12b9385b44813af117faad928b7d3.shtml. Accessed on 2020-03-28.
|
16. |
Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019. Clin Infect Dis, 2020, 71(16): 2027-2034.
|
17. |
Gao Z, Xu Y, Guo Y, et al. A systematic review of re-detectable positive virus nucleic acid among COVID-19 patients in recovery phase. Infect Genet Evol, 2020, 85: 104494.
|